Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 657.14K CAD in the quarter ending November 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to 2.78M, up 72.84% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.

• Revenue (ttm): 2.78M
• Revenue Growth: +72.84%
• P/S Ratio: 7.05
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 19.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	2.09M	1.06M	104.34%
Feb 29, 2024	1.02M	302.13K	42.06%
Feb 28, 2023	718.30K	-1.03M	-59.00%
Feb 28, 2022	1.75M	996.72K	131.98%
Feb 28, 2021	755.20K	653.70K	644.06%